Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle Cell
Completed
- Conditions
- Sickling Disorder Due to Hemoglobin SAnemia, Sickle Cell
- First Posted Date
- 2015-09-28
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- Chattanooga-Hamilton County Hospital Authority
- Target Recruit Count
- 9
- Registration Number
- NCT02561312
- Locations
- 🇺🇸
Chidlren's Hospital at Erlanger, Chattanooga, Tennessee, United States
Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes
Not Applicable
Terminated
- Conditions
- Diabetes Mellitus, Type 1Diabetic Ketoacidosis
- Interventions
- First Posted Date
- 2015-09-14
- Last Posted Date
- 2020-09-23
- Lead Sponsor
- Chattanooga-Hamilton County Hospital Authority
- Target Recruit Count
- 17
- Registration Number
- NCT02548494
- Locations
- 🇺🇸
Children's @ Erlanger, Chattanooga, Tennessee, United States
Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2013-12-06
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- Chattanooga-Hamilton County Hospital Authority
- Target Recruit Count
- 240
- Registration Number
- NCT02002546
- Locations
- 🇺🇸
Erlanger Baroness Medical Center, Chattanooga, Tennessee, United States
News
No news found